A Structural/Functional Domain on Human CD36 Is Involved in the Binding of Anti-Nak^α Antibodies

Summary

The human CD36 antigen is an integral membrane glycoprotein expressed by platelets, monocytes, endothelial cells and various tumor cell lines. CD36 acts as a receptor for thrombospondin, collagen, Plasmodium falciparum-infected erythrocytes and oxidized low- density lipoprotein. Individuals possessing the Nak^a-negative phenotype do not express CD36 and risk developing anti-CD36 isoantibodies upon blood transfusion or during pregnancy. In the present study, we have examined the interaction of an anti-Nak^a serum with recombinantly expressed CD36. Results obtained show that five functional CD36 monoclonal antibodies (OKM5, FA6-152, L103, ESIV-C7 and 10/5) prevent the binding of the anti-Naka serum whereas a single monoclonal antibody (13/10) has no effect. Consistent with this result, an epitope map of CD36 generated using cross-blocking experiments, indicates that the inhibitory monoclonal antibodies recognize closely- related epitopes whereas 13/10 reacts with a distinct CD36 determinant. Furthermore, we have demonstrated, in a recent study, that OKM5, FA6-152, L103 and 10/5 bind to the same CD36 domain defined by amino acids 155 to 183. Taken together, our results indicate that the 155-183 sequence is important for the binding of the anti-Nak^a serum to CD36 and may represent a surface-exposed, immunogenic and presumably functional region on human CD36.

• References

• 1 Asch AS, Barnwell J, Silverstein RJ, Nachmann RL. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987; 79: 1054-1061
• 2 Tandon NN, Kralisz U, Jamieson GA. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583
• 3 Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum infected erythrocytes. Cell 1989; 58: 95-101
• 4 Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-11816
• 5 Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992; 90: 1513-1522
• 6 Aiken ML, Ginsberg MH, Byers-Ward V, Plow EF. Effects of OKM5,a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990; 76: 2501-2509
• 7 Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991; 88: 7844-7848
• 8 Schüepp BJ, Pfister H, Clemetson KJ, Silverstein RL, Jungi TW. CD36- mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem Biophys Res Commun 1991; 175: 263-270
• 9 Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekigushi S. A new platelet-specific antigen, Nak(a), involved in the refractoriness of HLA-matched platelet transfusions. Vox Sang 1989; 57: 213-217
• 10 Tomiyama Y, Take H, Ikeda H, Mitani T, Furubayashi T, Mizutani T, Yamamoto N, Sekiguchi S, Tandon NN, Jamieson GA, Kurata Y, Yonezawa T, Tarui S. Identification of the platelet-specific alloantigen, Nak^a, on platelet membrane glycoprotein IV. Blood 1990; 75: 684-687
• 11 Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, Mitani T, Sekiguchi S, Lipsky R, Kralisz U, Jamieson GA. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Nak^a- platelets lack detectable GPIV (CD36). Blood 1990; 76: 1698-1703
• 12 Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-1115
• 13 Yamamoto N, Akamatsu N, Sakuraba H, Yamasaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the absence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392-397
• 14 Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752
• 15 Gautier C, Mehtali M, Lathe R. A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res 1989; 17: 8389
• 16 Daviet L, Buckland R, Puente Navazo MD, McGregor JL. Identification of an immunodominant,functional domain on human CD36 using human- mouse chimeric proteins and homologue replacement mutagenesis. Biochem J 1994; 305: 221-224
• 17 Dransfield I, Haslett C, Savill J. CD36 mAbs: binding to human monocyte- derived macrophages and inhibition of recognition of neutrophils undergoing apoptosis. Tissue Antigens (5th International Conference on Human Leukocyte Differenciation Antigens) 1993; 42: 416
• 18 Turner GD H, Craig AG, Pinches RA, Newbold CI, Berendt AR. Characterization of anti-CD36 antibodies from platelet panel. Tissue Antigens (5th International Conference on Human Leukocyte Differenciation Antigens) 1993; 42: 410
• 19 LaSala JM, Pearce FS, Silverstein RL. Reactivity of anti-CD36 panel against transfected cells, platelets, and purified platelets CD36. Tissue Antigens (5th International Conference on Human Leukocyte Differenciation Antigens) 1993; 42: 416
• 20 Okumura T, Jamieson GA. Platelet glycocalicin. Orientation of glycoproteins of the human platelet surface J Biol Chem 1976; 251: 5944-5949